The company said its VOLT system received CE mark and its Inhance Intact system won FDA 510(k) clearance. It showcased these technologies, alongside several others, at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego.
VOLT, a variable angle optimized locking technology, combines dynamic compression with variable angle locking without compromising stability in a plating system. The company launched VOLT last fall in the U.S. and plans to roll it out in Europe this year.
Johnson & Johnson MedTech’s Inhance Intact, a proprietary instrument set, is used with the Inhance shoulder system in subscapularis-sparing (SCS) total anatomic shoulder replacements. Combined with the TruMatch 3D pre-surgical planning cloud system, it enables a personalized approach to patient anatomy.
The company also has on display its Velys robotic-assisted solution, FDA-cleared for unicompartmental knee arthroplasty (UKA), along with the integrated Attune Knee system and Sigma HP implant. It also developed a new platform integrating standalone navigation with next-generation active robotic technology for Velys Spine.
Other showings include the Kincise surgical automated system, AI-powered Advance Case Management and new wound closure and healing offerings.
“With over 1.7 billion people worldwide living with musculoskeletal conditions—more than cancer, heart, and lung diseases combined—the need for effective, scalable orthopedic solutions has never been greater. At AAOS 2025, we are excited to showcase how our innovations are transforming the full ecosystem of orthopedic procedures to meet this growing demand,” said Aldo Denti, group chair, Orthopaedics, Johnson & Johnson MedTech. “By seamlessly integrating innovative implants, advanced surgical techniques, and data-driven enabling technologies, we’re helping surgeons advance patient care while improving efficiency for hospitals and ambulatory surgery centers.”
